ACTRN12617001370392已完成不适用
2-Year Cerebral Performance Category at Hospital Discharge According To Initial Rhythm And Resuscitation Time
Konya Numune State Hospital0 个研究点目标入组 44 人开始时间: 2017年9月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 —（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Evaluation of indirect restorationsClass II caries lesionsCAD/CAM,Ceramic Block,Hybrid Block,Indirect RestorationTCTR20191212002Erciyes University60
已完成
不适用
Clinical Assessment of Caries Restorations in the posterior tooth with bulk-fill resiDental CariesDental LeakageDental Restoration WearDental Restoration FailureC07.793.720.210C07.793.221E06.780.346.737.125E06.323.400RBR-9z6hx2Instituto de Ciência e Tecnologia - Universidade Estadual Paulista
进行中（未招募）
不适用
A Phase II Multi-Center, Double-Blind, Ascending Dose, Placebo-Controlled, Dose-Finding Trial of CER-001 or Placebo in Subjects with Acute Coronary Syndrome - CHI SQUARESymptoms of Acute Coronary SyndromeMedDRA version: 12.1Level: LLTClassification code 10051592Term: Acute coronary syndromeMedDRA version: 12.1Level: PTClassification code 10051592Term: Acute coronary syndromeEUCTR2010-023611-34-NLCerenis Therapeutics500
进行中（未招募）
1 期
A Phase II, 12-Week Randomised, Double-Blind, Placebo-Controlled, Proof of Concept Study to Evaluate Safety, Tolerability, Pharmacokinetics and Effect On Glycemic Control of P1736-05 in Subjects with Type 2 Diabetes Mellitus - P1736-05 POC studyDiabetes mellitus, type 2 (Blood Glucose Lowering Effect)EUCTR2009-016382-29-CZPiramal Life Sciences Limited20
进行中（未招募）
不适用
A Phase II, 12-Week Randomised, Double-Blind, Placebo-Controlled, Proof of Concept Study to Evaluate Safety, Tolerability, Pharmacokinetics and Effect On Glycemic Control of P1736-05 in Subjects with Type 2 Diabetes Mellitus - P1736-05 POC studyDiabetes mellitus, type 2 (Blood Glucose Lowering Effect)/EUCTR2009-016382-29-HUPiramal Life Sciences Limited40